Carterra 23/09/25
LB Bohle – 10.06.2025
Nipro Vialex – 26th January 2025
PCI – 7th June 2024
Temax_Krautz

Current Edition

Drug Discovery 2025, ELRIG – 04.07.2025
DDL 2025
Novo Nordisk 20 March 2024, 11:21
Carterra – 24th March 2025
HCMed

Homocysteine and Cognitive Impairment

One consequence of vitamin B12 deficiency is a raised blood level of homocysteine. This non-essential amino acid is derived from dietary protein. Its conversion to useful metabolites requires methyl-folate and vitamins B12 and B6 as cofactors. Blood levels of homocysteine therefore rise with deficiency of these important vitamins. Andrew McCaddon, Honorary Senior Research Fellow in the School of Medicine at Cardiff University, provides a case study of his finding of low B12 levels in families with early onset dementia and his search for evidence of deficiency in patients with late onset dementia.
 

https://international-pharma.com/wp-content/uploads/2012/12/1-Homocysteine-and-Cognitive-Impairment.pdf
YPSOMED website ad
Scott Pharma – 25.03.2025
Bespak – 21.05.2025
Woolcool 26 March 2024, 16:16
Biopharma group 6 March 2024, 09:40
EyeC 18 March 2024, 13:10
Nipro – 09.06.2025
Stoelzle – 15th May 2025
L.B. Bohle – 08.04.2025